Free USA Shipping Over $99
Free USA Shipping Over $99
Skip to content

KAL Think Magnesium & L-Threonate 60 Tablets

by Kal
$37.49

Notify me when back in stock

 

KAL Think Magnesium & L-Threonate 60 Tablets

Magnesium L-Theronate is a unique form of magnesium which readily crosses the blood-brain barrier making it a great form of magnesium to provide cognitive benefits as well as to help improve learning and memory. This vegan and vegetarian friendly formula contains 144mg of Magnesium per serving. 

KAL Think Magnesium & Threonate Highlights & Benefits

  • Supports Brain Function & Brain Health
  • May Help Improve Learning and Memory
  • Magnesium L-Threonate More Readily Crosses the Blood Brain Barrier
  • Vegan and Vegetarian Friendly
  • Non-GMO

Directions

Take 2 tablets daily with a meal and a glass of water. 

KAL Think Magnesium & L-Threonate 60 Tablets Ingredients

Warnings & Side Effects

Store in a cool dry place after opening. 

References

Shen Y, Dai L, Tian H, Xu R, Li F, Li Z, Zhou J, Wang L, Dong J, Sun L. Treatment Of Magnesium-L-Threonate Elevates The Magnesium Level In The Cerebrospinal Fluid And Attenuates Motor Deficits And Dopamine Neuron Loss In A Mouse Model Of Parkinson's disease. Neuropsychiatr Dis Treat. 2019 Nov 11;15:3143-3153. doi: 10.2147/NDT.S230688. PMID: 31806980; PMCID: PMC6857673.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857673/

Slutsky I, Abumaria N, Wu LJ, Huang C, Zhang L, Li B, Zhao X, Govindarajan A, Zhao MG, Zhuo M, Tonegawa S, Liu G. Enhancement of learning and memory by elevating brain magnesium. Neuron. 2010 Jan 28;65(2):165-77. doi: 10.1016/j.neuron.2009.12.026. PMID: 20152124.

https://pubmed.ncbi.nlm.nih.gov/20152124/

Blog posts

February 16, 2026 admin

What is ACP-105?

Is ACP-105 The Ultimate Recomp SARM? ACP-105 is a Selective Androgen Receptor Modulator or SARM. It was originally developed by Acadia Pharmaceuticals to help treat degenerative conditions like osteoporosis and muscle wasting. Unlike older performance enhancers ACP-105 was designed to...

Read now